Home » Pharma Units Not to Use Indian Raw Material

Pharma Units Not to Use Indian Raw Material

January 2, 2013

Pakistani pharmaceutical companies will not use raw material, imported from India, in their products in the light of Punjab government instructions.
Dawn

08Sep
Organizing Data and Document Archives: Finding a Needle in a Haystack for FDA Inspections
14Sep
Omnichannel Engagement: Are You Digitally Ready?
15Sep
Califf’s Post-PDUFA, Post-COVID FDA Agenda: Key Developments, Insights and Analysis
20Sep
Building a World-Class Pharmaceutical Advertising and Promotion Review Program
21Sep
The FDA’s Focus on Clinical Data Integrity Throughout Product Development and Approval
22Sep
FDA’s New Quality Management System Regulation: What the Proposed Harmonization with ISO 13485 Means for Devicemakers

Pharma Units Not to Use Indian Raw Material

Upcoming Events

Organizing Data and Document Archives: Finding a Needle in a Haystack for FDA Inspections

Omnichannel Engagement: Are You Digitally Ready?

Califf’s Post-PDUFA, Post-COVID FDA Agenda: Key Developments, Insights and Analysis

Building a World-Class Pharmaceutical Advertising and Promotion Review Program

The FDA’s Focus on Clinical Data Integrity Throughout Product Development and Approval

FDA’s New Quality Management System Regulation: What the Proposed Harmonization with ISO 13485 Means for Devicemakers

Featured Products

FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

Selecting and Implementing Electronic Document Management Systems in the EU

Featured Stories

Organogenesis Gets 510(k) Clearance to Expand PuraPly Portfolio

FDA Grants Priority Review to sNDA for Lynparza

Visibly Gets 510(k) Clearance for Its Online Eye Test

Resilience Inks Collaboration Deal With Mayo Clinic Over Biotherapeutics

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Pharma Units Not to Use Indian Raw Material

Related Events

The Revised ICH E8: A Guide to New Clinical Trial Requirements